Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma

Cytotechnology

Volumn 30, Issue 1-3, 1999, Pages 95-106

  Fassnacht, D ^a   Rossing S ^a   Singh, R P ^b   Al Rubeai, M ^b   Portner R ^a  

^a HAMBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Fixed bed; Hollow fibre; Hybridoma; Perfusion; Protein free medium

Indexed keywords

ANTIBODY PRODUCTION; BIOREACTOR; CELL CULTURE; HYBRIDOMA;

EID: 0345436063     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1008055702079     Document Type: Article

References (42)

1. Al-Rubeai M and Emery AN (1990) Mechanisms and kinetics of monoclonal antibody Synthesis and secretion in synchronous and asynchronous hybridoma cell cultures. J Biotechnol 16: 67-86.
2. Al-Rubeai M, Emery AN, Chalder S and Jan DC (1992) Specific antibody productivity and the cell cycle comparisons of batch, continuous and perfusion cultures. Cytotechnol 9: 85-97.
3. Al-Rubeai M, Mills D and Emery AN (1990) Electron microscopy of hybridoma cells with special regard to monoclonal antibody production. Cytotechnol 4: 13-28.
4. Amos B, Al-Rubeai M and Emery AN (1994) Hybridoma growth and monoclonal antibody production in a dialysis perfusion system. Enzyme Microb Technol 16: 688-695.
5. Boraston R, Thompson PW, Garland Sand Birch JR (1984) Growth and oxygen requirements of antibody producing mouse hybridoma cells in suspension culture. Develop Biol Standard 55: 103-111.
6. Cohen GM (1997) Caspases: The executioners of apoptosis. Biochemical J 326: 1-16.
7. Comer M, Kearns M, Wahl J, Munster M, Lorenz T, Szperalski B, Behrendt U and Brunner H (1990) Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation. Cytotechnol 3: 295-299.
8. Emery AN, Jan DCH and Al-Rubeai M (1995) Oxygenation of intensive cell-culture system. Appl Microbiol Biotechnol 43: 1028-1033.
9. Fassnacht D, Rössing S, Franék F, Al-Rubeai M and Pörtner R (1998a) Effect of bcl-2 expression on hybridoma cell growth in serum-supplemented, protein-free and diluted media. Cytotechnol 26: 119-226.
10. Fassnacht D, Rössing S, Stange J and Pörtner R (1998b) Longterm cultivation of immortalised mouse hepatocytes in a high cell density, fixed-bed reactor. Biotechnol Techniq 12: 25-30.
11. Fazekasde St. Groth S (1983) Automated production of monoclonal antibodies in a cytostat. J Immunol Methods 57: 121-136.
12. Franěk F and Dolníková J (1991) Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: Effect of nutrient concentration. Cytotechnol 7: 33-38.
13. Franěk F and Dolníková J (1991) Nucleosomes occuring in protein-free hybridoma cell cultures. Evidence for programmed cell death. FEBS Lett 248: 285-287.
14. Hager JC, Spiegelman S, Ramanarayanan M, Bausch J, Galletti PM and Calabresi P (1982) Tumour-assocated antigens produced by mouse mammary tumour cells in artifical capillary culture. J Natl Cancer Inst 69: 1359-1366.
15. Himmelfarb P, Thayer PS and Martin HE (1969) Spin-filter culture: the propagation of mammalian cells in suspension. Science 164: 555-557.
16. Huang DCS, Oreilly LA, Strasser A and Cory S (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 16: 4628-4638.
17. Itoh Y, Ueda H and Suzuki E (1995) Overexpession of bcl-2, apoptosis suppressing gene: prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng 48: 118-122.
18. Jan DCH, Emery AN and Al-Rubeai M (1993) Introducing spin filter eliminates hydrodynamic damage to hybridomas in bioreactor. Biotechnol Tech 7: 351-356.
19. Kim YH, Iida T, Fujita T, Terada S, Kitayama A, Ueda H, Prochownik EV and Suzuki E (1998) Establishment of an apoptosis-resistant and growth-controllable cell line by transfecting with inducible antisense c-jun gene. Biotechnol Bioeng 58: 65-72.
20. Linette GP, Li Y, Roth K and Korsmeyer SJ (1996) Cross talk between cell death and cell cyde progression: Bcl-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93: 9545-9552.
21. Mazel S, Burtrum D and Petrie HT (1996) Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 183: 2219-2226.
22. Mercille S and Massie B (1994) Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells. Biotechnol Bioeng 44: 1140-1154.
23. Mitchell-Logean C and Murhammer DW (1997) Bcl-2 express on in Spodoptera frugiperda and Trichoplusia ni BTI-Tn-5B 1-4 insect cells: Effect on recombinant protein expression and cell viability. Biotechnol Bioeng 56: 380-390.
24. Nagel A, Effenberger E, Koch S, Lübbe L, Marx U (1994) Human cancer and primary cell culture in the new hybrid bioreactor system technomouse. In: Spier RE, Griffiths JB and Berthold W (eds) Animal cell technology: products of today, prospects for tomorrow. (pp. 296-298) Butterworth-Heinemann.
25. Ong CP, Pörtner R, Märkl H, Yamazaki Y, Yasuda K and Matsumura M (1994) High density cultivation of hybridoma in charged porous carriers J Biotechnol 34: 259-268.
26. O'Reilly L, Huang DCS and Strasser A (1996) The cell death inhibitor bcl-2 and its homologues influence control of cell cycle entry. EMBO J 15: 6979-6990.
27. O'Reilly LA, Harris AW and Strasser A (1997a) Bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8-Tcell progenitors Int Immunol 9: 1291-1301.
28. O'Reilly LA, HarrisAW, Tarlinton DM, Corcoran LM and Strasser A (1997b) Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J Immunol 159: 2301-2311.
29. Perreault J and Lemieux R (1994) Essential role of optimal protein-synthesis in preventing the apoptotic death of cultured b-cell hybridomas Cytotechnol 13: 99-105.
30. Pörtner R, Rössing S, Koop M and Lüdemann I (1997) Kinetic studies on hybridoma cells immobilised in fixed-bed reactors. Biotechnol Bioeng 55: 535-541.
31. Reuveny S, Velez D, Miller L and MacMillan JD (1986) Comparison of cell propagation methods for their effect on monoclonal antibody yeild in fermentors J Immunol Methods 86: 61-69.
32. Simpson N, Milner, AN and Al-Rubeai M (1997) Prevention of hybridoma cell death by bcl-2 during sub-optimal culture conditions Biotechnol Bioeng 54: 1-16.
33. Simpson NH, Singh RP and Al-Rubeai M (1998) Manuscript in preparation.
34. Singh RP, Al-Rubeai M, Gregory CD and Emery AN (1994) Cell death in bioreactors a role for apoptosis Biotechnol Bioeng 44: 720-726.
35. Singh RP, Al-Rubeai M and Emery AN (1996) Apoptosis Exploiting novel pathways to the improvement of cell culture processes. Genet Eng Biotechnol 16: 227-251.
36. Singh RP, Emery AN and Al-Rubeai M (1996) Enhancement of survivability of mammalian cells by over-expression of the apoptosis supressor gene bcl-2. Biotechnol Bioeng 52: 166-175.
37. Suzuki E, Terada S, Ueda H, Fujita T, Komatsu T, Takayama S and Reed JC (1997) Establishing apoptosis resistant cell lines for improving protein productivity of cell culture. Cytotechnol 23: 55-59.
38. Tharakan JP and Chau PC (1986) A radial flow hollow fibre reactor for the large scale culture of mammalian cells. Biotechnol Bioeng 28: 329-342.
39. Tsujimoto Y, Cossman J, Jaff E and Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443.
40. Vaux DL, Cory S and Adam J (1988) bcl-2 gene promotes haemopoietic cell survival and co-operates with c-mycto immortilize pre-B- cells. Nature 335: 440-442.
41. - cotransporter induces apoptosis in hybridoma cells. Biotechnol Lett 20: 87-90.
42. Yang E and Korsmeyer SJ (1996) Molecular thanatopsis - a discourse on the bcl2 family and cell-death. Blood 88: 386-401.